港股上午盘三大指数集体上涨，恒生指数涨0.65%，国企指数涨0.5%，恒生科技指数涨1.14%，市场情 绪回暖。权重科技股拉升助力大市上行，其中美团涨超2%，腾讯、百度涨超1%；医药类股全线上涨， 机构预计2026年创新药景气度将持续向上，创新药概念股涨幅靠前；中资券商股、芯片股、铜业股普 涨。另外，石油股、影视股、体育用品股普跌，昨日强势领涨的航空股多数弱势。(格隆汇) ...

12月19日消息，港股三大指数集体上涨。截至午间收盘，恒生指数涨0.65%，报25663.41点，恒生科技 指数涨1.14%，国企指数涨0.50%。盘面上，科网股涨多跌少，美团涨超2%，网易、百度、腾讯涨超 1%，联想跌超1%；生物医药股普涨，药明康德涨超6%；中资券商股走强，招商证券涨超3%；智能驾 驶概念股活跃，佑驾创新涨超12%；今日智汇矿业、希迪智驾上市，智汇矿业涨超111%，希迪智驾跌 超8%。 | 名称 | | 量新价 | 涨跌幅 √ | | --- | --- | --- | --- | | 恒生科技指数 | N | 5480.00 | +1.14% | | 800700 | | | | | 恒生指数 | NV | 25663.41 | +0.65% | | 800000 | | | | | 国企指数 | Nº M | 8885.67 | +0.50% | | 800100 | | | | 生物医药股普涨，药明康德涨超6%。北京时间12月18日凌晨，参议院官网显示，搭载修订版《生物安 全法案》的美国2026财年国防授权法案（2026NDAA）获通过。新版本生物安全法未具体点名任何一家 公司。有券 ...

Group 1 - The core viewpoint of the article highlights a rebound in two major sectors of Hong Kong stocks: internet and innovative pharmaceuticals, with the Hong Kong Stock Connect Technology ETF (159101.SZ) rising by 1.5% [1] - Key stocks such as WuXi Biologics increased by over 6%, and WuXi AppTec rose by over 4%, while Tencent, Meituan, and Alibaba experienced slight increases [1] - After three months of adjustment, the crowdedness in these two core sectors has returned to low levels, with recent catalysts for growth including Tencent's release of the mixed reality model and Baidu's Kunlun chip accelerating towards an IPO, projected to exceed 2 billion yuan in revenue by 2025 [1] Group 2 - The passing of the U.S. National Defense Authorization Act for fiscal year 2026 on December 18 is seen as beneficial for CXO companies like WuXi Biologics and WuXi AppTec, as the new version of the biosafety law does not specifically name any companies [1] - Improved relations between the two countries have also boosted market risk appetite [1] - The Hong Kong Stock Connect Technology ETF (159101.SZ) tracks the National Index for Hong Kong Stock Connect Technology, which has reduced exposure to consumer retail while increasing allocation to biopharmaceuticals and hardware equipment, allowing for greater index elasticity [1]

Group 1 - The chairman of the China Securities Regulatory Commission, Wu Qing, emphasized the importance of implementing the "14th Five-Year Plan" for the capital market, focusing on risk prevention, strong regulation, and promoting high-quality development [1] - The State Administration for Market Regulation is pushing for a comprehensive rectification of "involution-style" competition to foster a market order characterized by quality and fair pricing [2] - The Ministry of Commerce has approved some general license applications for rare earth exports, indicating progress in export control policies [4] Group 2 - The Ministry of Commerce expressed strong opposition to the European Commission's investigations into several Chinese companies under the Foreign Subsidies Regulation, highlighting concerns over discrimination against foreign investment [5] - The China Photovoltaic Industry Association did not provide a forecast for the next year's new installed capacity, which is unusual for the annual conference, reflecting a cautious outlook for the industry [6] - Honda announced a temporary shutdown of its GAC Honda plant due to supply chain issues, specifically semiconductor shortages, which continues to impact production [7] Group 3 - Trump Media and Technology Group is merging with a fusion energy company backed by Alphabet, with a deal valued at over $6 billion, aiming to build large fusion power plants to meet energy demands driven by AI [8] - The U.S. stock market saw a collective rise in major indices, driven by favorable inflation data, with the Dow Jones increasing by 0.14% and the Nasdaq by 1.38% [9] - The Nasdaq Golden Dragon China Index rose by 0.97%, with several Chinese concept stocks experiencing gains, indicating a positive sentiment in the market [10] Group 4 - The Ministry of Commerce and the General Administration of Customs announced the implementation of export license management for steel products, aimed at enhancing monitoring and quality control [11] - OpenAI launched an application directory feature within ChatGPT, allowing users to access various third-party applications without downloads, which could impact the tech industry [12]

Market Overview - A-shares showed significant divergence with the Shanghai Composite Index rising by 0.16% to 3876.37 points, while the Shenzhen Component Index fell by 1.29% and the ChiNext Index dropped by 2.17% [1] - Total trading volume in the Shanghai and Shenzhen markets reached 16,770 billion, a decrease of 1,575 billion from the previous day [1] Banking Sector - The banking sector experienced a collective rebound, with major banks like Shanghai Bank and Chongqing Rural Commercial Bank rising over 3%, and others like Agricultural Bank and Industrial and Commercial Bank increasing by more than 2% [2] - The Central Economic Work Conference has set a favorable environment for banks to expand their balance sheets and provide long-term loans, while emphasizing the need to manage local and real estate risks [2] - According to CICC, listed banks are expected to see improved revenue and profit growth rates in 2026 and 2027 due to reduced net interest margin pressure and stable growth in fee income [2] - The average dividend yield for the banking sector is currently at 5.2%, significantly higher than the 10-year government bond yield, indicating a shift towards a "high dividend + high quality" investment cycle [2] AI Healthcare Sector - The AI healthcare sector saw strong gains, with stocks like Jiahe Meikang and Huaren Health hitting the daily limit of 20% increase, and others like Weining Health rising over 11% [3] - The Ant Group's AI health application "Antifufu" has seen a surge in downloads, reaching over 15 million monthly active users, indicating strong market interest [3] - The AI healthcare market in China has grown from 2 billion in 2019 to 6.4 billion in 2023, with projections to reach 224.4 billion by 2033, reflecting a compound annual growth rate of 43.1% [4] Commercial Aerospace Sector - The commercial aerospace sector experienced a surge, with companies like Xingchen Technology and Xice Testing hitting their daily limit, and others like Shunhao Co. and Tianjian Technology also seeing significant gains [5] - Xingchen Technology has reported successful delivery of products for commercial space applications, with plans for mass production starting in 2026 to meet increasing demand from private aerospace companies [6] - Recent policies and technological advancements are expected to accelerate the development of the commercial aerospace industry, with the National Space Administration promoting high-quality and safe development [7]

Group 1 - American investors are increasingly attracted to China's technology sector, with significant capital inflows into U.S.-listed ETFs focused on Chinese tech stocks, while non-tech funds are experiencing outflows [1][3] - The largest Chinese stock ETF in the U.S., KraneShares China Internet ETF (KWEB), has attracted $2.3 billion this year, potentially marking its best annual performance since 2021 [3] - In contrast, traditional sector-focused ETFs like iShares China Large-Cap ETF (FXI) have seen a net outflow of $2.3 billion this year, indicating a shift in investor sentiment towards technology [3] Group 2 - Analysts suggest that the launch of DeepSeek and trade tensions initiated by Trump have contributed to the inflow of funds into Chinese tech ETFs, with notable peaks in April and August aligning with tariff suspensions [3] - Citigroup's economists believe that China is rapidly catching up in both models and hardware in the AI sector, drawing parallels between the current state of the Chinese stock market and the U.S. market's past experiences [4] - Despite the competitive landscape between the U.S. and China in AI, American investors are increasingly investing in Chinese companies, with significant holdings in Alibaba and other tech firms [7] Group 3 - Investment firm Ruffer sees further upside for Chinese tech giants due to their lower price-to-earnings ratios compared to U.S. counterparts like Alphabet, indicating a potential undervaluation [10] - The chief investment officer of Krane Funds Advisors LLC highlights that the companies within KWEB are experiencing stock buybacks and attractive valuations, suggesting a possible revaluation of Chinese stocks by 2026 [10]

Group 1 - American investors are increasingly attracted to China's technology sector, with significant capital inflows into U.S.-listed ETFs focused on Chinese tech stocks, while non-tech funds are experiencing outflows [1][3] - The largest Chinese stock ETF in the U.S., KraneShares China Internet ETF (KWEB), has attracted $2.3 billion this year, potentially marking its best annual performance since 2021 [3] - In contrast, traditional sector-focused ETFs like iShares China Large-Cap ETF (FXI) have seen a net outflow of $2.3 billion this year [3] Group 2 - Analysts suggest that the launch of DeepSeek and trade tensions initiated by former President Trump have contributed to the inflow of funds into Chinese tech ETFs [3] - Citigroup's economists believe that China is rapidly catching up in both models and hardware in the AI sector, with 2025 being a pivotal year for narrowing the gap with the U.S. [4] - Despite the competitive landscape, U.S. investors are continuing to invest in Chinese companies involved in AI, with significant interest from hedge funds and venture capital firms [7] Group 3 - Ruffer, a London-based investment firm, sees further upside for Chinese tech giants due to their lower price-to-earnings ratios compared to U.S. counterparts like Alphabet [10] - The chief investment officer of Krane Funds Advisors LLC highlights that the companies within KWEB are experiencing stock buybacks and attractive valuations, suggesting a potential revaluation of Chinese stocks by 2026 [10] - Major U.S. investment firms, including Vanguard and BlackRock, have increased their holdings in Alibaba, indicating a growing confidence in Chinese tech stocks [7][10]

按管理资产规模计，在美上市最大中国股票ETF——KraneShares中国海外互联网ETF(KWEB)今年以来已累计吸金23亿美元，有望创 下2021年以来最佳年度表现。 以下文章来源于科创板日报 ，作者潇湘 科创板日报 . 专注科创板和科技创新，上海报业集团主管主办，界面财联社出品。 随着数以十亿美元计的资金在今年"用脚投票"，美国投资者似乎逐渐"迷上"了中国科技自强的愿景，而这种热情目前仍有望延续至新的一 年。 根据业内汇总的数据显示，2025年迄今，专注于中国科技股的美国主要上市ETF已吸引了大量资金流入，反观那些聚焦非科技板块的基金 则遭遇了资金流出。 资产规模排名第四的景顺中国科技ETF(CQQQ)也录得21亿美元资金流入，有望创下历史最佳年度表现。 iShares MSCI中国ETF(MCHI)则吸引了8.71亿美元新资金，有望终结此前连续两年的流出态势。 与此形成鲜明对比的是，专注传统板块的iShares中国大盘股ETF(FXI)今年迄今净流出了23亿美元；德意志银行旗下的Xtrackers Harvest 中证300ETF(ASHR)同期也遭遇了14亿美元的资金撤离。 景顺主题及专业ETF策略 ...

Market Overview - A-shares showed significant divergence on the 18th, with the Shanghai Composite Index slightly rising by 0.16% to 3876.37 points, while the Shenzhen Component Index fell by 1.29% and the ChiNext Index dropped by 2.17% [1] - The total trading volume in the Shanghai, Shenzhen, and North markets was 16,770 billion yuan, a decrease of 1,575 billion yuan from the previous day [1] Banking Sector - The banking sector saw a notable rise, with Shanghai Bank and Chongqing Rural Commercial Bank increasing by over 3%, while major banks like Ningbo Bank, China Construction Bank, Industrial and Commercial Bank of China, and Agricultural Bank of China rose by more than 2% [2] - The Central Economic Work Conference emphasized fiscal and investment support, creating a favorable environment for banks to expand their balance sheets and provide medium to long-term loans [2] - Analysts from China International Capital Corporation (CICC) noted that banks have entered a high-quality development phase, with some listed banks experiencing double-digit profit growth year-on-year [2] AI Healthcare Sector - The AI healthcare concept saw strong gains, with stocks like Jiahe Meikang and Huaren Health hitting the daily limit of 20% increase, while Weining Health rose over 11% [3][4] - The rapid growth of the "Ant Health" app, which surpassed 15 million monthly active users, indicates a significant market interest in AI healthcare solutions [5] - The AI healthcare market in China is projected to grow from 2 billion yuan in 2019 to 6.4 billion yuan in 2023, with an expected compound annual growth rate of 43.1% from 2023 to 2033 [5] Commercial Aerospace Sector - The commercial aerospace concept became active again, with Xice Testing rising over 12% and several other companies like Shunhao Co., Tianjian Technology, and Western Materials hitting the daily limit [6][7] - Analysts from CITIC Securities highlighted that the commercial aerospace industry is entering a new era supported by national policies and technological breakthroughs [9] - The industry encompasses various segments, including remote sensing applications, satellite control systems, and space computing, indicating a broad scope for investment opportunities [9]

Group 1: Reward Economy - The concept of "Reward Economy" refers to consumers purchasing non-essential goods or experiential services within their financial means to gain immediate pleasure, self-affirmation, and psychological healing in response to work and life pressures [1] - Stocks related to the Reward Economy, such as Guangbo Co., Aojiahua, Ruibeka, and Deyi Culture, saw significant price increases, with some reaching the daily limit [1] Group 2: Consumer Sector Performance - The consumer sector showed strong performance, particularly in areas like film exhibition, IP economy, and beer, with notable gains [2] - The film "Zootopia 2" has surpassed 3.6 billion yuan in box office revenue, while "Avatar 3" has already generated over 65 million yuan in pre-sales and screenings [3] Group 3: Collaboration and Market Trends - The success of "Zootopia 2" has led to collaborations across various sectors, including toys, dining, apparel, jewelry, and daily necessities, involving brands like Pop Mart and Luckin Coffee [4] - The new consumption investment sentiment is expected to shift from short-term narratives to sustainable business models and profitability, with a focus on health, new practicality, and emotional consumption [4] Group 4: Pharmaceutical Sector Activity - The pharmaceutical sector is experiencing active performance, with significant gains in medical commerce, family doctor services, and dental care [5] - Notable stocks include Shangyu Pimin and Yingte Group, both achieving substantial price increases [6] Group 5: Innovations in Healthcare - Ant Group has upgraded its AI health application to "Ant Aifu," focusing on comprehensive health management for users [7] - Baidu has launched the "Wenxin Health Steward," an AI-driven family health service, enhancing its healthcare offerings [7] Group 6: International Collaboration in Pharmaceuticals - The Chinese pharmaceutical industry is witnessing strong innovation and international collaboration, highlighted by a strategic partnership between Yaoyou Pharmaceutical and Pfizer worth over 2 billion USD [8] - The industry is moving towards internationalization and technological upgrades, with a focus on major business development transactions and companies with robust R&D pipelines [8]